3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Ectodermal Dysplasia: new trials by email Literature Review of Ectodermal Dysplasia trials Research Report on Ectodermal Dysplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita QTORIN 3.9% rapamycin anhydrous gel, Vehicle - Pachyonychia Congenita | Phase 3 | Completed | Palvella Therapeutics, Inc. | 87 | 2021-11-29 | 2024-08-29 |
| VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita PTX-022 - Pachyonychia Congenita | Phase 3 | Completed | Palvella Therapeutics, Inc. | 36 | 2020-09-01 | 2024-08-29 |
| Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita PTX-022, Placebo - Pachyonychia Congenita | Phase 2 / Phase 3 | Completed | Palvella Therapeutics, Inc. | 73 | 2019-04-01 | 2024-08-29 |
Abnormalities, Multiple (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Nail Diseases (3) · Skin Abnormalities (3) · Skin Diseases (3) · Skin Diseases, Genetic (3) · Skin and Connective Tissue Diseases (3)
Palvella Therapeutics, Inc. (3)
United States (3) · United Kingdom (1)
David Hansen, MD (2) · Joyce Teng, MD (2) · Amy Paller, MD (1)